Age-related macular degeneration AMD affects millions of people throughout the world. The intermediate stage may go undetected as it typically is asymptomatic. However the preferred practice patterns for AMD recommend identifying individuals with this stage of the disease to educate how to monitor for the early detection of the choroidal neovascular stage before substantial vision loss has occurred and to consider dietary supplements that might reduce the risk of the disease progressing from the intermediate to the advanced stage. Identification though can be time-intensive and requires expertly trained individuals. Automated Grading of Age-Related Macular Degeneration From Color Fundus Images Using Deep Convolutional Neural Networks.